Search

Robert B. Mondesi

Supervisory Patent Examiner (ID: 84, Phone: (571)272-0956 , Office: P/1652 )

Most Active Art Unit
1652
Art Unit(s)
1653, 1645, 1652
Total Applications
437
Issued Applications
180
Pending Applications
97
Abandoned Applications
166

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7163048 [patent_doc_number] => 20050085410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Artificial oxygen carrier and production method thereof' [patent_app_type] => utility [patent_app_number] => 10/927675 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6944 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085410.pdf [firstpage_image] =>[orig_patent_app_number] => 10927675 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/927675
Artificial oxygen carrier and production method thereof Aug 26, 2004 Issued
Array ( [id] => 6918117 [patent_doc_number] => 20050095678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Novel rat calcium channel subunits and related probes, cell lines and methods' [patent_app_type] => utility [patent_app_number] => 10/924081 [patent_app_country] => US [patent_app_date] => 2004-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13250 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20050095678.pdf [firstpage_image] =>[orig_patent_app_number] => 10924081 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/924081
Rat calcium channel subunits and related probes, cell lines and methods Aug 22, 2004 Issued
Array ( [id] => 7215655 [patent_doc_number] => 20050054574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Methods for modulating a drug-related effect or behavior' [patent_app_type] => utility [patent_app_number] => 10/913697 [patent_app_country] => US [patent_app_date] => 2004-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21159 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054574.pdf [firstpage_image] =>[orig_patent_app_number] => 10913697 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/913697
Methods for modulating a drug-related effect or behavior Aug 4, 2004 Issued
Array ( [id] => 7089621 [patent_doc_number] => 20050009734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Avian sternal cartilage composition and method of administering' [patent_app_type] => utility [patent_app_number] => 10/909204 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2521 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009734.pdf [firstpage_image] =>[orig_patent_app_number] => 10909204 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/909204
Avian sternal cartilage composition and method of administering Jul 29, 2004 Abandoned
Array ( [id] => 7127838 [patent_doc_number] => 20050059582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Use of soluble P-selectin and anthrax lethal toxin' [patent_app_type] => utility [patent_app_number] => 10/902489 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4124 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059582.pdf [firstpage_image] =>[orig_patent_app_number] => 10902489 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/902489
Use of soluble P-selectin and anthrax lethal toxin Jul 28, 2004 Abandoned
Array ( [id] => 7027282 [patent_doc_number] => 20050020809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases' [patent_app_type] => utility [patent_app_number] => 10/901243 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 28114 [patent_no_of_claims] => 133 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020809.pdf [firstpage_image] =>[orig_patent_app_number] => 10901243 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/901243
Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases Jul 28, 2004 Abandoned
Array ( [id] => 522139 [patent_doc_number] => 07186684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-06 [patent_title] => 'Hemostatic device containing a protein precipitate' [patent_app_type] => utility [patent_app_number] => 10/896455 [patent_app_country] => US [patent_app_date] => 2004-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4088 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/186/07186684.pdf [firstpage_image] =>[orig_patent_app_number] => 10896455 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/896455
Hemostatic device containing a protein precipitate Jul 21, 2004 Issued
Array ( [id] => 872655 [patent_doc_number] => 07361736 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-22 [patent_title] => 'Family 44 xyloglucanases' [patent_app_type] => utility [patent_app_number] => 10/896555 [patent_app_country] => US [patent_app_date] => 2004-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21966 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/361/07361736.pdf [firstpage_image] =>[orig_patent_app_number] => 10896555 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/896555
Family 44 xyloglucanases Jul 21, 2004 Issued
Array ( [id] => 7348495 [patent_doc_number] => 20040248259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'VELP2, a vascular endothelial cell specific and LIM domain containing molecule and uses therefor' [patent_app_type] => new [patent_app_number] => 10/889340 [patent_app_country] => US [patent_app_date] => 2004-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40359 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248259.pdf [firstpage_image] =>[orig_patent_app_number] => 10889340 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/889340
VELP2, a vascular endothelial cell specific and LIM domain containing molecule and uses therefor Jul 11, 2004 Abandoned
Array ( [id] => 5738485 [patent_doc_number] => 20060008876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis' [patent_app_type] => utility [patent_app_number] => 10/887540 [patent_app_country] => US [patent_app_date] => 2004-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 18106 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008876.pdf [firstpage_image] =>[orig_patent_app_number] => 10887540 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/887540
ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis Jul 6, 2004 Abandoned
Array ( [id] => 7428414 [patent_doc_number] => 20040265982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Compositions and methods for treating atherosclerosis' [patent_app_type] => new [patent_app_number] => 10/866330 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21546 [patent_no_of_claims] => 106 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265982.pdf [firstpage_image] =>[orig_patent_app_number] => 10866330 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/866330
Compositions and methods for treating atherosclerosis Jun 9, 2004 Issued
Array ( [id] => 7033644 [patent_doc_number] => 20050032154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Method for producing tripeptides and/or peptides longer than tripeptides' [patent_app_type] => utility [patent_app_number] => 10/859405 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23772 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032154.pdf [firstpage_image] =>[orig_patent_app_number] => 10859405 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/859405
Method for producing tripeptides and/or peptides longer than tripeptides Jun 2, 2004 Abandoned
Array ( [id] => 7024935 [patent_doc_number] => 20050019329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Methods of reducing vascular permeability in tissue by inhibition of tissue plasminogen activator (tPA) and tPA inhibitors useful therein' [patent_app_type] => utility [patent_app_number] => 10/849540 [patent_app_country] => US [patent_app_date] => 2004-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6419 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019329.pdf [firstpage_image] =>[orig_patent_app_number] => 10849540 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/849540
Methods of reducing vascular permeability in tissue by inhibition of tissue plasminogen activator (tPA) and tPA inhibitors useful therein May 19, 2004 Issued
Array ( [id] => 7128065 [patent_doc_number] => 20050059809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Methods and kits for purifying his-tagged proteins' [patent_app_type] => utility [patent_app_number] => 10/840408 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7387 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059809.pdf [firstpage_image] =>[orig_patent_app_number] => 10840408 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/840408
Methods and kits for purifying his-tagged proteins May 5, 2004 Issued
Array ( [id] => 616580 [patent_doc_number] => 07144992 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-05 [patent_title] => 'Synergistic antimicrobial compositions and methods for reducing biofilm formation' [patent_app_type] => utility [patent_app_number] => 10/826094 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 36 [patent_no_of_words] => 9411 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/144/07144992.pdf [firstpage_image] =>[orig_patent_app_number] => 10826094 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/826094
Synergistic antimicrobial compositions and methods for reducing biofilm formation Apr 15, 2004 Issued
Array ( [id] => 7250007 [patent_doc_number] => 20040258745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Pharmaceutical composition containing artificial oxygen carrier' [patent_app_type] => new [patent_app_number] => 10/819352 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8775 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20040258745.pdf [firstpage_image] =>[orig_patent_app_number] => 10819352 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/819352
Pharmaceutical composition containing artificial oxygen carrier Apr 6, 2004 Issued
Array ( [id] => 7428197 [patent_doc_number] => 20040265961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Novel proteins homologous to kinase suppressor of Ras' [patent_app_type] => new [patent_app_number] => 10/812232 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11112 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265961.pdf [firstpage_image] =>[orig_patent_app_number] => 10812232 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/812232
Novel proteins homologous to kinase suppressor of Ras Mar 28, 2004 Abandoned
Array ( [id] => 5700090 [patent_doc_number] => 20060216774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Method' [patent_app_type] => utility [patent_app_number] => 10/550647 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4624 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216774.pdf [firstpage_image] =>[orig_patent_app_number] => 10550647 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/550647
Method Mar 22, 2004 Abandoned
Array ( [id] => 528173 [patent_doc_number] => 07183399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-27 [patent_title] => 'Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same' [patent_app_type] => utility [patent_app_number] => 10/806930 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 7 [patent_no_of_words] => 16351 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/183/07183399.pdf [firstpage_image] =>[orig_patent_app_number] => 10806930 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/806930
Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same Mar 21, 2004 Issued
Array ( [id] => 498155 [patent_doc_number] => 07208588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-24 [patent_title] => 'Bt toxin receptors and methods of use' [patent_app_type] => utility [patent_app_number] => 10/798058 [patent_app_country] => US [patent_app_date] => 2004-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15035 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/208/07208588.pdf [firstpage_image] =>[orig_patent_app_number] => 10798058 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/798058
Bt toxin receptors and methods of use Mar 10, 2004 Issued
Menu